Zhitong Finance App News, Yuandong Biotech (688513.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for injectable rimazolam benzenesulfonate approved and issued by the State Drug Administration. The active ingredient in this product is rimazolam benzenesulfonate, which is a Class II psychotropic drug as stipulated in the National Regulations on the Administration of Narcotic Drugs and Psychotropic Substances. This product is used as a sedative for: (1) sedation and anesthesia during non-tracheal intubation surgery/operation; (2) induction and maintenance of general anesthesia.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.